Hi, I think years ago it was much more rah rah.. And with that exeperience came a hard lesson in investing.. Personally, a company with no support from management and no revenues to back up the BS, should have been a red flag right away.. Unfortunately, for many, myself included, it ended badly.. Some held, some sold and never returned ,and some sold and bought back in..
So I came back the 2nd time much wiser..First, did I still believe in the solution? yes.. Did new management satisfy my requirements? I was happy to see some of the leadership investing along side the shareholders.. This gave me a great deal of confidence.. Have revenues been growing? Yes.. These were the 3 most important criteria for myself.. Let's move forward to the current S1..
The S1 is only a prospectus.. While it is the intention of the board to implement a reverse, it does not mean the BOD will.. The misunderstanding of a reverse.. A reverse is considered positive if you are uplisting.. If trading on the Nasdaq already, it could be considered negative, to prevent from delisting.. In the first go around with CYRX.. While on surface the uplisting seemed positive, the dumb money (me) got played.. THERE WAS NO EXECUTION, no revenues, no insider support.. It was dubious at best..
Let me address dilution.. Dilution, no wants to dilute, but aggressive growth requires capital to grow.. The key to dilution is your rate of return.. Old management used the capital for G_D knows what, but new management seems to need the capital for true expansion.. So again, the key question, do you believe this time, the capital being invested will yield a return and create shareholder value???
In the end, we are all responsible for our own investment decisions. Message boards, and I have said this many times in the past.. Probably not the best place to do research, but we seem to need a board to voice our excitement or frustration..
